• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Pericardial Tamponade Caused by a Hypersensitivity Response to Tuberculosis Reactivation after Anti-PD-1 Treatment in a Patient with Advanced Pulmonary Adenocarcinoma.

作者信息

Chu Yi-Chun, Fang Ke-Chin, Chen Hsing-Chun, Yeh Yi-Chen, Tseng Chih-En, Chou Teh-Ying, Lai Chun-Liang

机构信息

Division of Pulmonology and Critical Care, Department of Internal Medicine, Buddhist Dalin Tzu Chi Hospital, Chiayi, Republic of China.

Department of Pathology and Laboratory Medicine, Taipei Veterans General Hospital, Taipei, Republic of China.

出版信息

J Thorac Oncol. 2017 Aug;12(8):e111-e114. doi: 10.1016/j.jtho.2017.03.012.

DOI:10.1016/j.jtho.2017.03.012
PMID:28748816
Abstract
摘要

相似文献

1
Pericardial Tamponade Caused by a Hypersensitivity Response to Tuberculosis Reactivation after Anti-PD-1 Treatment in a Patient with Advanced Pulmonary Adenocarcinoma.一名晚期肺腺癌患者在接受抗PD-1治疗后，因结核再激活的超敏反应导致心包填塞。
J Thorac Oncol. 2017 Aug;12(8):e111-e114. doi: 10.1016/j.jtho.2017.03.012.
2
Pericardial tamponade and coexisting pulmonary embolism as first manifestation of non-advanced lung adenocarcinoma.心包填塞和并存的肺栓塞作为非晚期肺腺癌的首发表现
Pan Afr Med J. 2014 May 3;18:15. doi: 10.11604/pamj.2014.18.15.2469. eCollection 2014.
3
Malignant pericardial effusion and cardiac tamponade.恶性心包积液与心脏压塞。
Acta Cytol. 1986 Nov-Dec;30(6):657-61.
4
[Case 2/92 (Instituto do Coração do Hospital das Clínicas-FMUSP)].
Arq Bras Cardiol. 1992 Mar;58(3):215-21.
5
[Cardiac tamponade as the initial manifestation of a pulmonary neoplasm].[心脏压塞作为肺部肿瘤的首发表现]
Med Clin (Barc). 1990 Dec 8;95(20):779-81.
6
Adenocarcinoma of the lung: pericardial tamponade as the major presenting feature.
Ohio State Med J. 1979 Jan;75(1):25-7.
7
[Cardiac tamponade as the first symptom of lung cancer].[心脏压塞作为肺癌的首发症状]
Pneumonol Alergol Pol. 2013;81(2):149-53.
8
Intrapericardial instillation of mitomycin C in recurrent cardiac tamponade due to malignant pericardial effusion.丝裂霉素C心包内注射治疗恶性心包积液所致复发性心脏压塞
Clin Oncol (R Coll Radiol). 2006 Aug;18(6):506. doi: 10.1016/j.clon.2006.04.002.
9
Cardiac tamponade as the first manifestation of bronchogenic carcinoma.心脏压塞作为支气管源性癌的首发表现。
Int Surg. 1985 Jan-Mar;70(1):75-7.
10
[Lung cancer manifested as cardiac tamponade: a case report].[以心包填塞为表现的肺癌：一例报告]
Kyobu Geka. 1995 Sep;48(10):890-2.

引用本文的文献

1
A rapidly progressive case of tuberculous pleurisy and pericarditis in a patient with non-small cell lung cancer that developed one month after receiving pembrolizumab monotherapy.一名非小细胞肺癌患者在接受派姆单抗单药治疗1个月后发生的快速进展性结核性胸膜炎和心包炎病例。
IDCases. 2025 Apr 19;40:e02234. doi: 10.1016/j.idcr.2025.e02234. eCollection 2025.
2
Characterization of Early Lesions of Human Post-Primary Tuberculosis and Its Progression to Necrosis Using Archival Material of the Pre-Antibiotic Era.利用抗生素时代之前的存档材料对人类原发性后结核病早期病变及其向坏死发展的特征进行研究。
Pathogens. 2025 Feb 25;14(3):224. doi: 10.3390/pathogens14030224.
3
The Impact of Infections in Patients Treated with Atezolizumab Plus Bevacizumab for Unresectable Hepatocellular Carcinoma.
阿替利珠单抗联合贝伐单抗治疗不可切除肝细胞癌患者中感染的影响
J Clin Med. 2024 Aug 23;13(17):4994. doi: 10.3390/jcm13174994.
4
A narrative review of the controversy on the risk of mycobacterial infections with immune checkpoint inhibitor use: does Goldilocks have the answer?关于使用免疫检查点抑制剂引发分枝杆菌感染风险争议的叙述性综述：金发姑娘知道答案吗？
J Thorac Dis. 2024 Feb 29;16(2):1601-1624. doi: 10.21037/jtd-23-1395. Epub 2024 Feb 27.
5
Pulmonary Tuberculosis Following Immune Checkpoint Inhibitor Treatment for Recurrent Maxillary Squamous Cell Carcinoma.免疫检查点抑制剂治疗复发性上颌鳞状细胞癌后发生的肺结核
Cureus. 2024 Jan 29;16(1):e53203. doi: 10.7759/cureus.53203. eCollection 2024 Jan.
6
Increased Tuberculosis Reactivation Risk in Patients Receiving Immune Checkpoint Inhibitor-Based Therapy.接受免疫检查点抑制剂治疗的患者结核再激活风险增加。
Oncologist. 2024 Apr 4;29(4):e498-e506. doi: 10.1093/oncolo/oyad340.
7
A comprehensive review on immune checkpoint inhibitors induced cardiotoxicity characteristics and associated factors.免疫检查点抑制剂引起的心脏毒性特征及相关因素的全面综述。
Eur J Med Res. 2023 Nov 8;28(1):495. doi: 10.1186/s40001-023-01464-1.
8
Tuberculosis infection following immune checkpoint inhibitor treatment for advanced cancer: a case report and literature review.免疫检查点抑制剂治疗晚期癌症后的结核感染：病例报告及文献复习。
Front Immunol. 2023 May 25;14:1162190. doi: 10.3389/fimmu.2023.1162190. eCollection 2023.
9
Increased Tuberculosis Incidence Due to Immunotherapy Based on PD-1 and PD-L1 Blockade: A Systematic Review and Meta-Analysis.免疫治疗药物阻断 PD-1/PD-L1 通路导致的结核病发病率增加：一项系统评价和荟萃分析。
Front Immunol. 2022 May 19;13:727220. doi: 10.3389/fimmu.2022.727220. eCollection 2022.
10
Serial interferon-gamma release assay in lung cancer patients receiving immune checkpoint inhibitors: a prospective cohort study.肺癌患者接受免疫检查点抑制剂治疗时的序贯干扰素-γ释放试验：一项前瞻性队列研究。
Cancer Immunol Immunother. 2022 Nov;71(11):2757-2764. doi: 10.1007/s00262-022-03198-1. Epub 2022 Apr 16.